4.7 Article

Coronavirus Disease 2019 Vaccine Trials (and Tribulations): How to Improve the Process of Clinical Trials in a Pandemic

Journal

CLINICAL INFECTIOUS DISEASES
Volume 75, Issue SUPPL 1, Pages S5-S10

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciac301

Keywords

COVID-19 vaccine; clinical trials; study design; pandemic preparedness

Funding

  1. Sanofi
  2. Merck
  3. Pfizer
  4. Lilly
  5. Quidel

Ask authors/readers for more resources

This article reviews the importance of vaccine clinical trials in developing effective COVID-19 vaccines. It highlights the challenges of supply chain disruptions, infection control, study designs, and participant factors, as well as specific solutions to streamline the clinical trial process.
Vaccine clinical trials were essential to developing effective severe acute respiratory syndrome coronavirus 2 vaccines. The challenges of supply chain disruptions, infection control, study designs, and participant factors are reviewed, along with ways to streamline the clinical trial process. Vaccine clinical trials have been essential to developing effective severe acute respiratory syndrome coronavirus 2 vaccines. The challenges of supply chain disruptions, infection control, study designs, and participant factors that affect trial procedures are reviewed, with specific solutions to streamline the clinical trial process.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available